{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:09:51Z","timestamp":1779923391765,"version":"3.53.1"},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,10,15]]},"DOI":"10.2169\/internalmedicine.4488-20","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T22:06:09Z","timestamp":1593468369000},"page":"2619-2622","source":"Crossref","is-referenced-by-count":10,"title":["Severe Bradycardia Induced by Sofosbuvir and Amiodarone which Resolved after the Discontinuation of Both Drugs"],"prefix":"10.2169","volume":"59","author":[{"given":"Chikako","family":"Monoe","sequence":"first","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Tokyobay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Tokyobay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanae","family":"Kitaguchi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Tokyobay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiraku","family":"Funakoshi","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Tokyobay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology. JSH guidelines for the management of hepatitis C virus infection: a 2014 update for genotype 1. Hepatol Res 44: 59-70, 2014.","DOI":"10.1111\/hepr.12272"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med 356: 935-941, 2007.","DOI":"10.1056\/NEJMct065916"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Desai AD, Chun S, Sung RJ. The role of intravenous amiodarone in the management of cardiac arrhythmias. Ann Intern Med 127: 294-303, 1997.","DOI":"10.7326\/0003-4819-127-4-199708150-00007"},{"key":"4","unstructured":"4. Linzer M, Yang EH, Estes NA 3rd, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 1: value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 126: 989-996, 1997."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Calkins H, Shyr Y, Frumin H, Schork A, Morady F. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med 98: 365-373, 1995.","DOI":"10.1016\/S0002-9343(99)80315-5"},{"key":"6","unstructured":"6. Moya A. Taskforce for the diagnosis and management of syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS). Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 30: 2631-2671, 2009."},{"key":"7","unstructured":"7. Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC\/AHA\/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 70: e39-e110, 2017."},{"key":"8","unstructured":"8. Back DJ, Burger DM. Interaction between amiodarone and sofosbuvir-based treatment for hepatitis C virus infection: potential mechanisms and lessons to be learned. Gastroenterology 149: 1315-1317, 2015."},{"key":"9","unstructured":"9. Renet S, Chaumais MC, Antonini T, et al. Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge. Gastroenterology 149: 1378-1380, 2015."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4488-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T03:43:17Z","timestamp":1602906197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4488-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":9,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4488-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}